Deep learning approach for Parkinson’s disease classification from facial expressions: A pilot feasibility study
Objective: To apply deep learning and traditional machine learning approaches to images of different facial expressions from patients and controls to aid in the prediction…Sustained Improvement in Freezing of Gait (FOG) and Treatment Satisfaction at 12 months After Initiation of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients in USA: Interim Results from the PROviDE Study
Objective: To evaluate the long-term effectiveness of CLES on FOG and treatment satisfaction in APD patients. Background: FOG, prevalent in about 60% of APD patients,…High-frequency rTMS over the primary motor cortex relieves musculoskeletal pain in Parkinson’s disease: A randomized controlled trial
Objective: To study the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) over primary motor cortex(M1) on musculoskeletal pain(MSP) in patients with Parkinson’s disease. Background:…Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes
Objective: This meta-analysis is aimed to explore the association between thiazolidinedione (TZD) use and Parkinson’s disease (PD) risk. Background: Recent epidemiological studies found protective effects of TZD class of drugs in…The genetic study of hereditary chorea in Kazakhstan
Objective: To analyze the genetic background of hereditary chorea in Kazakhstani population. Background: Hereditary chorea (HC) is a group of inherited movement disorders presenting with…Are New York City rail tracks harbingers for Parkinson’s disease?
Objective: To describe the clinical features of 7 New York City Metropolitan Transit Authority (NYC MTA) rail-track workers with Parkinson’s disease (PD) presenting to a…Can clinical outputs predict BDNF levels in people with Parkinson’s disease?
Objective: To modelling the relationship between Brain-Derived Neurotrophic Factor (BDNF) levels and clinical variables (stages of disease and cognition) in people with Parkinson's disease (PD).…Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality
Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…An introduction to the Global Parkinson’s Genetics Program (GP2)
Objective: Expanding the current understanding of the genetic architecture of Parkinson’s disease (PD), accelerate discovery and validation of novel disease-causing genetic mutations and provide training…Whole-exome sequencing in early-onset Parkinson’s disease among ethnic Chinese
Objective: The objectives of this study were to assess the genetic and clinical features of early-onset Parkinson’s disease (EOPD) among ethnic Chinese from mainland China.…
- « Previous Page
- 1
- …
- 88
- 89
- 90
- 91
- 92
- …
- 405
- Next Page »